- New INTERACT2 Publication
October 24, 2013
A new INTERACT2 article titled “Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2″ (Guofang Chen, et al, for the INTERACT2 Investigators) has just been published in the Stroke AHA Journal. Continue reading
- INTERACT2 results reaches over 32 million people!
July 23, 2013
Through TV interviews, radio, newspaper and online sources including social media, the news that there is new hope for stroke survivors has reached 32,125,697 people worldwide. Also, new INTERACT2 resources are now available. Continue reading
- INTERACT2 Results Revealed!
May 29, 2013
The wait is over! The INTERACT2 results have just been announced at the European Stroke Conference 2013. The INTERACT2 Trial has found that early intensive blood pressure lowering is safe and produces better levels of recovery in survivors. Continue reading
The second (main phase) of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial or INTERACT2, is one of the largest ever clinical trial in acute intracerebral haemorrhage (ICH) that has been conducted to date. Recruitment finished at the end of August 2012 and 2839 patients participated from 144 hospitals around the world. The results were announced at the European Stroke Conference in 2013 and were also published in the New England Journal of Medicine. The study answered an important clinical question of whether early and intensive lowering of high blood pressure after an ICH will improve the chances of a patient surviving free of major disability.
In this website, you will be able to find information on the study, our results, download our newsletters and information sheets, and read about the latest news and publications. If you are a Health Professional, please navigate to the Health Professional section to find information appropriate for your needs.
For more information on stroke, visit your national Stroke Foundation or Association website.
For Australia, please visit http://www.strokefoundation.com.au/